Dr. Efrat Dotan is an oncologist in Philadelphia. She provides diagnostic and treatment services for patients suffering from all types of cancer.
Please Note: This link will direct you to a third-party website unaffiliated with MD.com (https://www.fccc.edu/myFoxChase/patients/enrollment/index.html), where you're able to request or schedule an appointment online with Dr. Efrat Dotan.
Yes, Dr. Efrat Dotan is accepting new patients at this office.
333 Cottman Avenue, Philadelphia, PA 19111
Yes, Dr. Efrat Dotan is accepting new patients at this office.
(215) 728-2773
333 Cottman Avenue, Gen Surg Assoc of Fccc Mgi, Philadelphia, PA 19111-2434
Dr. Efrat Dotan graduated from Other in 2002.
Dr. Dotan has two offices in Pennsylvania where she specializes in Oncology and Internal Medicine.
Dr. Dotan works with one hundred and nineteen doctors including Dr. Richard Bleicher and Dr. Mary Martin.
As an oncologist, Dr. Dotan is trained to diagnose and treat all types and forms of cancer. Dr. Dotan may employ a variety of diagnostic tests such as biopsies, imaging tests, endoscopic tests and laboratory tests. She may offer treatment techniques such as chemotherapy or radiotherapy to combat the spread of cancer. Dr. Dotan may also provide emotional and palliative care, ensuring patients experience the highest quality of life possible.
The specialty of internal medicine is an area of primary care for adults. Dr. Dotan specializes in diagnosing and treating cross-system illnesses that may affect multiple organ systems. When necessary, Dr. Dotan can also refer patients to specialist physicians when medically needed. As an example, patients with severe liver problems could be referred to a hepatologist for additional medical tests or treatments.
Other
MD • 2002
Please Note: The information displayed below is sourced from the 2014 Medicare Physician and Other Supplier National Provider Identifier (NPI) Aggregate Report. It's important to remember that the statistics below are not inclusive of all patients treated by Dr. Dotan, but only those who participate in Medicare.